Results 221 to 230 of about 111,074 (325)
Proteomic and Allergenomic Profiling of Banana (<i>Musa</i> spp.): Identification of Potential Novel Allergens in Thai Adult Banana Allergy Cohort. [PDF]
Sangsuwan P +10 more
europepmc +1 more source
Abstract Objective To describe the real‐world safety, tolerability, and effectiveness of eptinezumab for chronic migraine prevention in Australia. Background Eptinezumab is a relatively new medication for treatment‐resistant chronic migraine prevention.
Lakshini Gunasekera +7 more
wiley +1 more source
Two Cases of Anaphylaxis After Laminaria Insertion [PDF]
Sang Hoon Kim +6 more
openalex +1 more source
Overcoming anaphylactic severe cow's milk allergy with slow and low-dose oral immunotherapy: A 10-year path to tolerance. [PDF]
Yamamoto S +3 more
europepmc +1 more source
ABSTRACT Aims To explore parents’ experiences of parenting adolescents with food allergies. Design An interpretive descriptive qualitative study. Methods Semi‐structured interviews were conducted between November 2023 and March 2024 with 11 parents of adolescents with food allergies aged 12–16 years, 8 mothers and 3 fathers. Reflexive thematic analysis
Meg O’ Sullivan +4 more
wiley +1 more source
Recurrent Airway Swelling in a Patient With Lymphoproliferative Disorder: A Diagnostic Challenge Between Anaphylaxis and Acquired Angioedema. [PDF]
Nahid MH, Khan B, Munshi R.
europepmc +1 more source
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin +24 more
wiley +1 more source
Scombroid and Anaphylaxis: Different Diseases Despite Featural Similarities. [PDF]
Oliveira N, Junqueira V, Amorim R.
europepmc +1 more source

